Great Lakes Pharmaceuticals Garners $3,100,000 Series B Financing

  • Feed Type
  • Date
    7/27/2010
  • Company Name
    Great Lakes Pharmaceuticals
  • Mailing Address
    2000 Auburn Dr. Beachwood, OH 44122
  • Company Description
    Great Lakes is a clinical-stage company focused on eliminating microbial infections associated with biofilm formation.
  • Website
    http://www.glpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,100,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Company intends to use the funds to complete a pivotal clinical study of B-Lock, an antimicrobial catheter lock solution.
  • M&A Terms
  • Venture Investor
    Charter Life Sciences Fund
  • Venture Investor
    Early Stage Partners, LP
  • Venture Investor
    Ohio TechAngels Fund
  • Venture Investor
    North Coast Angel Fund

Trending on Xconomy